Health Skyhawk Therapeutics Secures $2 Billion Boost from Merck KGaA Skyhawk Therapeutics has received a significant funding boost of $2 billion from Merck KGaA, marking a pivotal moment in the development of RNA therapeutics.... Editorial3 hours ago